Trading Update – Q1 2022 Sales up 84% to £2.38m (Q1 2021: £1.29m)
Deepverge PLC (AIM:DVRG) MoU with Abingdon Health for lateral flow tests
DeepVerge and Abingdon Health plc sign MoU for Commercial Agreement for Lateral Flow Tests in Modern Water Household Devices
TPI provides its latest research note on DeepVerge plc (AIM:DVRG)
DeepVerge has announced that the first six installations of Modern Water’s post-pandemic Microtox®PD wastewater pathogen detection system have been deployed to various sites in the UK, as part of the
Deepverge PLC (AIM:DVRG) 1st UK Deployments of Microtox®PD in Wastewater
First UK Deployments of Microtox®PD Pathogen Detection Systems in UK Wastewater
Deepverge PLC (AIM:DVRG) Acquisition; Loan Facility for global expansion
Acquisition of engineering services company for £ 1.1 million to assemble Microtox®PD in-house
TPI provides its latest research note on DeepVerge plc (AIM:DVRG)
DeepVerge has announced a 39% increase in production orders for Modern Water equipment in Q1 2022, taking its current order book to around £5m for a range of drinking water
Deepverge PLC (AIM:DVRG) DeepVerge Q1 production orders up 39% to £5m
DeepVerge production orders up 39% worth £5m for Modern Water equipment in Q1
TPI provides its latest research note on DeepVerge plc (DVRG.L)
DeepVerge’s consumer skin test subsidiary brand, Skin Trust Club, has announced further significant growth of its platform. Since mid-January, 10 leading skincare manufacturers have enlisted on the Skin Trust App
Deepverge PLC (AIM: DVRG) 82% of Skin Trust Club members purchase via App
Skin Trust Club continues rapid growth
Deepverge PLC (DVRG.L) MicrotoxPD detects 3 COVID variants of concern
Analysis of Microtox®PD chips coated with Optimer binding agents detect 3 common variants of concern of SARS-CoV-2 virus
TPI provides its latest research note on DeepVerge plc (DVRG.L)
DeepVerge has released a post-31 December 2021 year-end trading update along with a statement detailing its outlook for the current year.
